StockData
Neogen Corp logo

Neogen Corp (NEOG) income statement

NEOGNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Aug 31, 2026Last filing: 10-Q on Oct 7, 2026Score 7/3053% above fair value
$11.08+0.18 (+1.65%)

Close on Nov 18, 2026Market cap $2.42BP/E –Yield –

Neogen Corp income statement

Ratios

Latest available, balances at Aug 31, 2026

Profitability, TTM

Gross margin
47.4%
Operating margin
-0.8%
Net margin
-6.3%
Return on equity, FY2026
-0.4%

Financial strength

Current ratio
3.90
Debt to equity
0.74
Debt to assets
47.1%
Cash to current liabilities
115.1%

Valuation

P/E ratio
–
Price to sales
2.74
Price to book
1.16
Dividend yield
–

See a number that looks wrong?